CANNAPHARMARX, INC. Selling, General and Administrative Expense
CANNAPHARMARX, INC. (CPMD) reported Selling, General and Administrative Expense of $116.64 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-04-10
- CANNAPHARMARX, INC. selling, general and administrative expense for the quarter ending 2024-12-31 was -$136.73K.
- CANNAPHARMARX, INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $51.23K, a 84.78% decline year-over-year.
- CANNAPHARMARX, INC. selling, general and administrative expense for the quarter ending 2023-12-31 was -$153.98K.
- CANNAPHARMARX, INC. selling, general and administrative expense for the quarter ending 2023-09-30 was $336.62K.
- CANNAPHARMARX, INC. selling, general and administrative expense for fiscal 2024 was $116.64K, a 83.42% decline from fiscal 2023.
- CANNAPHARMARX, INC. selling, general and administrative expense for fiscal 2023 was $703.60K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$136.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | -$85.51K derived: sum of 2 quarters · filed 2025-04-10 | $116.64K 10-K · filed 2025-04-10 | |
| 2024-09-30 | $51.23K 10-Q · filed 2024-11-14 | $253.37K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | -$153.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $182.64K derived: sum of 2 quarters · filed 2025-04-10 | $703.60K 10-K · filed 2025-04-10 | |
| 2023-09-30 | $336.62K 10-Q · filed 2024-11-14 | $857.57K 10-Q · filed 2024-11-14 |